RDY vs. NATCOPHARM.NS
Compare and contrast key facts about Dr. Reddy's Laboratories Limited (RDY) and Natco Pharma Limited (NATCOPHARM.NS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RDY or NATCOPHARM.NS.
Correlation
The correlation between RDY and NATCOPHARM.NS is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RDY vs. NATCOPHARM.NS - Performance Comparison
Key characteristics
RDY:
-0.21
NATCOPHARM.NS:
-0.12
RDY:
-0.14
NATCOPHARM.NS:
0.13
RDY:
0.98
NATCOPHARM.NS:
1.02
RDY:
-0.24
NATCOPHARM.NS:
-0.11
RDY:
-0.52
NATCOPHARM.NS:
-0.42
RDY:
9.04%
NATCOPHARM.NS:
12.07%
RDY:
22.30%
NATCOPHARM.NS:
39.85%
RDY:
-58.55%
NATCOPHARM.NS:
-89.98%
RDY:
-19.49%
NATCOPHARM.NS:
-47.46%
Fundamentals
RDY:
$11.49B
NATCOPHARM.NS:
₹149.48B
RDY:
$0.74
NATCOPHARM.NS:
₹104.11
RDY:
18.32
NATCOPHARM.NS:
8.02
RDY:
$317.20B
NATCOPHARM.NS:
₹42.77B
RDY:
$189.51B
NATCOPHARM.NS:
₹33.10B
RDY:
$69.94B
NATCOPHARM.NS:
₹24.75B
Returns By Period
In the year-to-date period, RDY achieves a -14.12% return, which is significantly higher than NATCOPHARM.NS's -39.74% return. Over the past 10 years, RDY has underperformed NATCOPHARM.NS with an annualized return of 4.41%, while NATCOPHARM.NS has yielded a comparatively higher 12.84% annualized return.
RDY
-14.12%
-8.99%
-18.49%
-4.58%
12.12%
4.41%
NATCOPHARM.NS
-39.74%
-32.56%
-41.83%
-21.13%
5.73%
12.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RDY vs. NATCOPHARM.NS — Risk-Adjusted Performance Rank
RDY
NATCOPHARM.NS
RDY vs. NATCOPHARM.NS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and Natco Pharma Limited (NATCOPHARM.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RDY vs. NATCOPHARM.NS - Dividend Comparison
RDY's dividend yield for the trailing twelve months is around 7.07%, more than NATCOPHARM.NS's 0.87% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RDY Dr. Reddy's Laboratories Limited | 7.07% | 6.07% | 4.21% | 7.39% | 0.52% | 0.46% | 0.71% | 3.94% | 0.83% | 3.28% | 3.37% | 3.00% |
NATCOPHARM.NS Natco Pharma Limited | 0.87% | 0.41% | 1.17% | 1.11% | 0.39% | 0.91% | 1.18% | 1.25% | 0.75% | 0.35% | 0.17% | 0.33% |
Drawdowns
RDY vs. NATCOPHARM.NS - Drawdown Comparison
The maximum RDY drawdown since its inception was -58.55%, smaller than the maximum NATCOPHARM.NS drawdown of -89.98%. Use the drawdown chart below to compare losses from any high point for RDY and NATCOPHARM.NS. For additional features, visit the drawdowns tool.
Volatility
RDY vs. NATCOPHARM.NS - Volatility Comparison
The current volatility for Dr. Reddy's Laboratories Limited (RDY) is 8.64%, while Natco Pharma Limited (NATCOPHARM.NS) has a volatility of 26.98%. This indicates that RDY experiences smaller price fluctuations and is considered to be less risky than NATCOPHARM.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RDY vs. NATCOPHARM.NS - Financials Comparison
This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and Natco Pharma Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities